63
The structure of the agreement is in line with the agreements recently announced by Teva and also includes a significant component of the supply of life-saving drugs to the extent of the season – or even exceeds – the current need for Rhode Island for the next 10 years, adding expenses for the trial March 16, 2022. The company continues to conduct active negotiations in order to reach a nationwide settlement in the United States.
More in-
Teva said in a statement that “Teva believes that the agreement it reached today with the State of Rhode Island is a critical step towards achieving life-saving treatments for people suffering from opioid addiction. .